DRUG Stock: Bright Minds Biosciences Inc. Stock Price, Analysis & Insights

Get live DRUG stock price $61.56, comprehensive Bright Minds Biosciences Inc. stock analysis, charts, news, and expert forecast. Real-time DRUG stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

61.56

9.20%Today

DRUG • Bright Minds Biosciences Inc. • NASDAQ Capital Market • Healthcare

Market Cap

477.80M

Volume

708.26K

52W High

123.75

52W Low

23.18

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Bright Minds Biosciences Inc. is a preclinical biotechnology firm dedicated to creating serotonin-based therapies. Its primary goal is to enhance the well-being of individuals suffering from severe and life-altering conditions. The company's developm...

Contact Information

Website: https://brightmindsbio.com
Address: 1500 – 1055 West Georgia Street
Country: CA

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: -0.11) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Bright Minds Biosciences Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Bright Minds Biosciences Inc.
⚠Investors should consider how Bright Minds Biosciences Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

477.80M

P/E Ratio (TTM)

-25.13

Beta

-0.11

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare DRUG with peer companies:

Altimmune, Inc. (ALT)

Price: $2.61
Market cap: 230.35M

Annexon, Inc. (ANNX)

Price: $4.72
Market cap: 564.49M

Aura Biosciences, Inc. (AURA)

Price: $6.12
Market cap: 392.90M

DiaMedica Therapeutics Inc. (DMAC)

Price: $5.33
Market cap: 287.20M

Design Therapeutics, Inc. (DSGN)

Price: $10.66
Market cap: 665.79M

enGene Holdings Inc. (ENGN)

Price: $1.60
Market cap: 81.91M

Galectin Therapeutics Inc. (GALT)

Price: $2.38
Market cap: 156.74M

I-Mab (IMAB)

Price: $2.88
Market cap: 235.66M

Korro Bio, Inc. (KRRO)

Price: $10.59
Market cap: 105.41M

LB Pharmaceuticals Inc Common Stock (LBRX)

Price: $28.39
Market cap: 814.13M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.